Elucidating stearoyl metabolism and NCOA4-mediated ferroptosis in gastric cancer liver metastasis through multi-omics single-cell integrative mendelian analysis: advancing personalized immunotherapy strategies
Zhongqiu Yang,
No information about this author
Yuquan Chen,
No information about this author
Yaping Miao
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 15, 2025
The
metabolism
of
stearoyl-GPE
plays
a
key
role
in
the
liver
metastasis
gastric
cancer.
This
investigation
delves
into
mechanisms
underlying
intricate
tumor
microenvironment
(TME)
heterogeneity
triggered
by
stearoyl
cancer
with
(LMGC),
offering
novel
perspectives
for
LMGC.
Utilizing
Mendelian
randomization,
we
determined
that
significantly
contributes
to
progression
(GC).
Following
this,
bulk
transcriptome
analyses
and
single-cell
multiomics
techniques
investigate
roles
metabolism-related
genes,
particularly
NCOA4,
regulating
LMGC
TME.
Our
analysis
highlights
crucial
modulating
complex
LMGC,
impacting
monocyte
cells.
Through
sequencing
spatial
transcriptomics,
have
identified
metabolic
genes
specific
within
cell
population,
including
NCOA4.
Regarding
relationship
between
ferroptosis,
metabolism,
findings,
it
is
plausible
pathways
intersect
involved
ferroptosis.
Ferroptosis,
characterized
iron-dependent
lipid
peroxidation,
represents
regulated
form
death.
activity
Stearoyl-CoA
desaturase
(SCD),
critical
enzyme
has
been
associated
modulation
composition
susceptibility
Furthermore,
integral
cellular
processes
related
oxidative
stress
both
which
are
significant
factors
context
study
enhances
understanding
ferroptosis
promoting
its
regulation
heterogeneity.
In
addition,
this
deeper
dynamics
provides
basis
development
better
interventions
combat
metastasis.
Language: Английский
Integrating multi-omics and experimental techniques to decode ubiquitinated protein modifications in hepatocellular carcinoma
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 11, 2025
Background
Ubiquitination,
a
critical
post-translational
modification,
plays
pivotal
role
in
regulating
protein
stability
and
activity,
influencing
various
aspects
of
cancer
development,
including
metabolic
reprogramming,
immune
evasion,
tumor
progression.
However,
the
specific
ubiquitination
hepatocellular
carcinoma
(HCC),
particularly
relation
to
microenvironment
(TME),
remains
poorly
understood.
This
study
aims
systematically
explore
shaping
TME
HCC,
with
focus
on
its
impact
progression
modulation.
Methods
We
performed
bioinformatics
analysis
by
integrating
multiple
publicly
available
HCC
datasets
assess
status
across
cell
types
TME,
plasma
cells,
fibroblasts,
endothelial
epithelial-mesenchymal
transition
(EMT)
cells.
Ubiquitination
scores
were
calculated
categorize
these
types,
survival
data,
along
spatial
transcriptomics,
employed
evaluate
how
different
levels
influence
In
vitro
experiments,
such
as
transwell,
CCK8,
wound
healing
assays,
used
further
investigate
key
gene
UBE2C
phenotypes.
Results
Our
revealed
that
ubiquitination-related
genes
are
significantly
upregulated
tissues,
high
expression
correlating
poor
prognosis
patients.
Pathway
showed
enriched
processes
cycle
regulation,
DNA
repair,
p53
signaling.
These
pathways
contribute
promoting
proliferation,
facilitating
matrix
remodeling,
enhancing
angiogenesis.
Notably,
UBE2C,
enzyme,
appears
play
potentially
inhibiting
anti-tumor
responses
reducing
system’s
ability
recognize
eliminate
Furthermore,
experimental
data
confirmed
overexpression
promotes
invasion,
metastasis,
supporting
remodeling.
Conclusion
reveals
multifaceted
regulatory
roles
HCC.
not
only
supports
proliferation
anti-apoptotic
functions
within
cells
but
also
modulating
activity
stromal
Among
all
genes,
emerges
potential
prognostic
biomarker
therapeutic
target
offering
new
directions
for
precision
treatment
future.
Language: Английский
Integrated single-cell RNA sequencing reveals the tumor heterogeneity and microenvironment landscape during liver metastasis in adenocarcinoma of esophagogastric junction
Junrui Xu,
No information about this author
Ussama Sadiq,
No information about this author
Wenxue Zhao
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 9, 2025
Adenocarcinoma
of
the
esophagogastric
junction
(AEGJ)
is
a
highly
aggressive
tumor
that
frequently
metastasizes
to
liver.
Understanding
cellular
and
molecular
mechanisms
drive
this
process
essential
for
developing
effective
therapies.
We
employed
single-cell
RNA
sequencing
analyze
heterogeneity
microenvironmental
landscape
in
patients
with
AEGJ
liver
metastases.
This
approach
enabled
us
characterize
diverse
cell
populations
involved
metastatic
process.
Our
analysis
revealed
significant
involvement
fibroblasts
mural
cells
metastasis.
identified
specific
fibroblast
type
metastasis
observed
distinct
gene
expression
patterns
between
adenocarcinoma
other
stomach
adenocarcinomas.
study
demonstrated
high
SFRP2
pericyte
during
AEGJ.
The
incorporation
GEO,
TCGA,
immunofluorescence
staining
enhanced
our
study.
High
pericytes
may
influence
vascular
stability
angiogenesis
through
Wnt
pathway.
provides
novel
insights
into
interactions
underlie
Targeting
subtype
or
influencing
offer
new
therapeutic
strategies
combating
tumor.
Language: Английский
Causal Association Between Microbiome and Oral-Oropharyngeal Cancer: A Mendelian Randomization Study
International Dental Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
From big data and experimental models to clinical trials: Iterative strategies in microbiome research
Cell,
Journal Year:
2025,
Volume and Issue:
188(5), P. 1178 - 1197
Published: March 1, 2025
Microbiome
research
has
expanded
significantly
in
the
last
two
decades,
yet
translating
findings
into
clinical
applications
remains
challenging.
This
perspective
discusses
persistent
issue
of
correlational
studies
microbiome
and
proposes
an
iterative
method
leveraging
silico,
vitro,
ex
vivo,
vivo
toward
successful
preclinical
trials.
The
evolution
methodologies,
including
shift
from
small
cohort
to
large-scale,
multi-cohort,
even
"meta-cohort"
analyses,
been
facilitated
by
advancements
sequencing
technologies,
providing
researchers
with
tools
examine
multiple
health
phenotypes
within
a
single
study.
integration
multi-omics
approaches-such
as
metagenomics,
metatranscriptomics,
metaproteomics,
metabolomics-provides
comprehensive
understanding
host-microbe
interactions
serves
robust
hypothesis
generator
for
downstream
vitro
research.
These
hypotheses
must
then
be
rigorously
tested,
first
proof-of-concept
experiments
clarify
causative
effects
microbiota,
goal
deep
mechanistic
understanding.
Only
following
these
phases
can
conducted
translation
clinic.
We
highlight
importance
combining
traditional
microbiological
techniques
big-data
approaches,
underscoring
necessity
diverse
model
systems
enhance
translational
potential
Language: Английский
Exploring novel biomarkers and immunotherapeutic targets for biofeedback therapies to reveal the tumor-associated immune microenvironment through a multimetric analysis of kidney renal clear cell carcinoma
Guobing Wang,
No information about this author
Jinbang Huang,
No information about this author
Haiqing Chen
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 13, 2025
Kidney
renal
clear
cell
carcinoma
(KIRC)
constitutes
the
primary
subtype
of
carcinoma,
representing
75%
to
80%
cases
and
carrying
a
substantial
cancer-specific
mortality
rate
up
24%.
Despite
advancements
in
treatment
options,
KIRC
displays
notable
resistance
conventional
therapies,
emphasizing
need
for
innovative
targeted
immunotherapeutic
strategies.
Chromatin
regulators
(CRs),
pivotal
proteins
controlling
gene
expression
critical
biological
processes,
play
crucial
role
initiation
progression
KIRC.
This
study
employed
multi-omics
approach
evaluate
impact
CR-associated
genes
on
prognosis.
The
utilized
TCGA-KIRC
dataset
LASSO
Cox
regression
construct
validate
prognostic
model
that
focuses
influencing
research
investigated
interactions
among
characteristics,
clinical
parameters,
tumor
microenvironment,
immunotherapy,
drug
responsiveness.
Experimental
validation,
encompassing
various
techniques
such
as
culture,
transient
transfection,
qPCR,
Transwell
assays,
confirmed
robust
predictive
capability
BRD9
gene.
analysis
identified
risk
score
CRs
an
independent
factor
determining
Furthermore,
introduced
Nomogram
integrates
attributes
assessment.
Significantly,
exhibited
substantially
elevated
within
cells,
underscoring
its
driving
cancer
proliferation,
invasion,
migration.
These
findings
suggest
potential
tailored
immunotherapy
targeting
presents
framework
based
approaches,
seamlessly
incorporating
CRs.
holds
promise
improving
accuracy
prognosis
prediction
patients,
laying
foundation
development
immunotherapies.
Language: Английский
Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights
Quanjun Lin,
No information about this author
Zhiqiang Wang,
No information about this author
Jue Wang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 9, 2024
Colorectal
cancer
(CRC)
is
a
leading
cause
of
cancer-related
deaths
globally.
The
heterogeneity
the
tumor
microenvironment
significantly
influences
patient
prognosis,
while
diversity
cells
shapes
its
unique
characteristics.
A
comprehensive
analysis
molecular
profile
crucial
for
identifying
novel
targets
drug
sensitivity
and
uncovering
pathophysiological
mechanisms
underlying
CRC.
Language: Английский
Exploring the role of Disulfidptosis in glioma progression: insights into tumor heterogeneity and therapeutic potential through single-cell RNA sequencing
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 23, 2024
Gliomas,
particularly
glioblastoma
(GBM),
are
the
most
common
and
aggressive
primary
brain
tumors
in
adults,
characterized
by
high
malignancy
frequent
recurrence.
Despite
standard
treatments,
including
surgery,
radiotherapy,
chemotherapy,
prognosis
for
GBM
remains
poor,
with
a
median
survival
of
less
than
15
months
five-year
rate
below
10%.
Tumor
heterogeneity
resistance
to
treatment
create
significant
challenges
controlling
glioma
progression.
Therefore,
there
is
an
urgent
need
new
therapeutic
targets
strategies.
This
study
investigates
role
Disulfidptosis,
recently
discovered
form
programmed
cell
death,
gliomas.
Unlike
apoptosis
necrosis,
Disulfidptosis
driven
abnormal
accumulation
intracellular
disulfide
bonds,
leading
protein
misfolding
cytoskeletal
collapse,
cancer
cells
metabolic
dysregulation.
We
aim
explore
how
respond
identify
potential
analyzing
gliomas
at
single-cell
level
using
RNA
sequencing
(scRNA-seq).
scRNA-seq
data
from
patients
were
analyzed
uncover
differences
ferroptosis-related
pathways,
iron
metabolism
lipid
peroxidation.
Cellular
subpopulations
within
profiled
assess
their
sensitivity
underlying
mechanisms.
Survival
analysis
was
conducted
evaluate
clinical
relevance
Disulfidptosis-related
gene
expression.
Multiple
exhibit
varying
sensitivities
influenced
properties.
Dysregulated
antioxidant
mechanisms
identified
as
key
factors
impacting
sensitivity.
Glioma
microenvironment
signaling
pathways
also
play
regulating
Disulfidptosis.
These
findings
suggest
that
activating
may
provide
novel
strategies
overcome
offers
insights
into
progression
highlights
its
target.
By
leveraging
data,
research
uncovers
tumor
identifies
specific
populations
resistant
pave
way
personalized
improve
outcomes
patients.
Language: Английский
Mitochondria: a crucial factor in the progression and drug resistance of colorectal cancer
Ying Zhao,
No information about this author
Xiaomin Guo,
No information about this author
Li Zhang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 23, 2024
Colorectal
cancer
(CRC),
as
one
of
the
malignant
tumors
with
highest
incidence
and
mortality
rates
worldwide
in
recent
years,
originating
primarily
from
mucosal
tissues
colon
or
rectum,
has
potential
to
rapidly
develop
into
invasive
cancer.
Its
pathogenesis
is
complex,
involving
a
multitude
factors
including
genetic
background,
lifestyle,
dietary
habits.
Early
detection
treatment
are
key
improving
survival
for
patients
CRC.
However,
pervasive
problem
that
can
become
severely
resistant
treatment,
which
greatly
increases
complexity
challenge
treatment.
Therefore,
unraveling
overcoming
resistance
CRC
focus
research.
Mitochondria,
energy
centers
cell,
play
crucial
role
cellular
metabolism,
supply,
apoptosis
process.
In
CRC,
Mitochondrial
dysfunction
not
only
impairs
normal
cell
function
but
also
promotes
tumor
resistance.
deep
understanding
relationship
between
mitochondrial
mechanisms
development,
well
by
it
chemotherapy
drugs,
development
targeted
therapies,
enhancing
drug
efficacy,
outcomes
quality
life
patients.
Language: Английский
Multi-omics analysis reveals the role of the autophagy-related gene AGT in chemotherapy resistance in colorectal cancer and the therapeutic potential of its inhibitors
Wenjiao Cai,
No information about this author
Xiang Tao,
No information about this author
Xiaoli Liu
No information about this author
et al.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 18, 2024
Autophagy
is
a
crucial
mechanism
for
maintaining
cellular
homeostasis
and
responding
to
environmental
stress,
it
closely
linked
tumor
drug
resistance.
Through
multi-omics
analysis,
this
study
explores
the
expression
patterns,
functions,
potential
role
of
autophagy-related
gene
Angiotensinogen
(AGT)
in
colorectal
cancer
(CRC),
particularly
relation
chemotherapy
This
first
compared
AGT
between
CRC
normal
tissues
using
GTEx
TCGA
databases.
Differences
were
assessed
Wilcoxon
Rank
Sum
Tests,
prognostic
impact
was
evaluated
through
univariate
Cox
survival
analysis
meta-analysis.
Functional
enrichment
performed
limma
fgsea
packages.
Drug
sensitivity
conducted
based
on
CTRP
database,
while
immune
infiltration
CIBERSORT
ESTIMATE
methods.
Spatial
transcriptomic
characteristics
explored
10x
Visium
technology
deconvolution
investigate
correlation
levels
cell
content.scRNA-seq
data
from
sourced
Tumor
Immune
Single
Cell
Hub
(TISCH).Functional
annotation
with
Single-sample
set
(SSGSEA),
pseudotime
Monocle
2
mapped
their
developmental
trajectories.
The
inhibitors
treatment
analyzed
drug-target
Mendelian
randomization.Finally,
Phenome-Wide
Association
Study
(PheWAS)
evaluate
genetic
associations
side
effects
inhibitors.
significantly
higher
associated
shorter
recurrence-free
(RFS).
signaling
pathways
markedly
enriched
high
group.
positively
correlated
resistance
chemotherapeutic
agents
such
as
gemcitabine,
cisplatin,
paclitaxel,
5-fluorouracil.
revealed
that
predominantly
expressed
malignant
regions.
Single-cell
identified
21
distinct
subpopulations
across
13
major
types.
samples,
especially
fibroblast
C6
subpopulation.
Tumor-related
C1,
C5,
C6,
C8
subpopulations.
Pseudotime
these
subpopulations,
terminal
stages.Drug-target
randomization
indicated
negative
causal
relationship
risk
both
heart
failure(ORdrug
=
0.950,
95%
CI,
0.912–0.990;
P
0.014)
CRC(ORdrug
0.874,
CI:
0.792–0.964;
0.007).PheWAS
showed
no
other
traits,
indicating
its
specificity
low
effects.
Elevated
chemotherapy,
inhibition
may
offer
therapeutic
avenue
cancer.
Language: Английский